Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now displays a 403 Forbidden message, indicating that access to the record is blocked. The page shows standard site chrome around the error content, rather than the study details.SummaryDifference19%

- Check35 days agoChange DetectedThe page shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a minor maintenance update to the ClinicalTrials.gov study page rather than changes to study content.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision tag v3.6.5 was added and the previous tag v3.6.4 was removed. This reflects a behind-the-scenes build update to the page.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the prior Revision: v3.6.3. This indicates a minor site update without altering study details or results.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page footer shows a revision label updated from v3.6.2 to v3.6.3, indicating a software version bump. This appears to be an internal maintenance update rather than a modification to the study content or data displayed on the page.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page footer revision has been updated from v3.6.0 to v3.6.2, reflecting a small platform update.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.